PL2814473T3 - Kompozycje farmaceutyczne do terapii skojarzonej - Google Patents

Kompozycje farmaceutyczne do terapii skojarzonej

Info

Publication number: PL2814473T3
Authority: PL; Poland
Prior art keywords: pharmaceutical compositions; combination therapy; therapy; combination; pharmaceutical
Prior art date: 2012-02-16

Application number

PL13703834T

Other languages

English (en)

Inventor

Henrik Björk HANSEN

Morten Grunnet

Bo Hjorth BENTZEN

Lars HYVELED-NIELSEN

Jørgen Buus Lassen

Claus Sundgreen

Original Assignee

Saniona A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-02-16

Filing date

2013-02-14

Publication date

2019-06-28

2013-02-14 Application filed by Saniona A/S filed Critical Saniona A/S

2019-06-28 Publication of PL2814473T3 publication Critical patent/PL2814473T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

PL13703834T 2012-02-16 2013-02-14 Kompozycje farmaceutyczne do terapii skojarzonej PL2814473T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US201261599623P	2012-02-16	2012-02-16
DKPA201270076		2012-02-16
EP13703834.5A EP2814473B1 (en)	2012-02-16	2013-02-14	Pharmaceutical compositions for combination therapy
PCT/EP2013/052941 WO2013120935A1 (en)	2012-02-16	2013-02-14	Pharmaceutical compositions for combination therapy

Publications (1)

Publication Number	Publication Date
PL2814473T3 true PL2814473T3 (pl)	2019-06-28

Family

ID=48983571

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL13703834T PL2814473T3 (pl)	2012-02-16	2013-02-14	Kompozycje farmaceutyczne do terapii skojarzonej

Country Status (15)

Country	Link
US (5)	US9211271B2 (pl)
EP (1)	EP2814473B1 (pl)
JP (1)	JP6203760B2 (pl)
CN (3)	CN108434129A (pl)
AU (1)	AU2013220424B2 (pl)
CA (1)	CA2864264C (pl)
DK (1)	DK2814473T3 (pl)
EA (1)	EA029543B1 (pl)
ES (1)	ES2704987T3 (pl)
HK (1)	HK1204946A1 (pl)
HR (1)	HRP20190050T1 (pl)
LT (1)	LT2814473T (pl)
PL (1)	PL2814473T3 (pl)
SI (1)	SI2814473T1 (pl)
WO (1)	WO2013120935A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2814473B1 (en) *	2012-02-16	2018-10-10	Saniona A/S	Pharmaceutical compositions for combination therapy
CN105940759B (zh) *	2013-12-28	2021-01-22	英特尔公司	基于用户上下文检测的装置动作和配置的***和方法
SI3265126T1 (sl) *	2015-03-03	2021-11-30	Saniona A/S	Formulacija kombinacije tezofenzina in metoprolola
EP3402473A1 (en)	2016-01-15	2018-11-21	Saniona A/S	Tesofensine and metoprolol for treatment of hypertension
US9949964B2 (en)	2016-09-07	2018-04-24	Saniona A/S	Tesofensine compositions
US20220160658A1 (en)	2019-01-07	2022-05-26	Saniona A/S	Tesofensine for reduction of body weight in prader-willi patients
CN110297826B (zh) *	2019-05-31	2020-12-11	南京理工大学	基于json动态解析卫星遥测数据的方法
MX2022013236A (es)	2020-04-22	2023-01-24	Saniona As	Tratamiento de la obesidad hipotalamica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0576617T3 (da)	1991-03-18	1996-12-30	Sepracor Inc	Præparat og fremgangsmåde indeholdende optisk rent (S) metoprolol
CN1077574C (zh)	1996-02-22	2002-01-09	神经研究公司	托烷衍生物,其制备和应用
JP2007519646A (ja)	2004-01-22	2007-07-19	ノイロサーチアクティーゼルスカブ	体重の持続的低減のための化合物
US20110118304A1 (en)	2007-11-20	2011-05-19	Neurosearch A/S	Method for treating over-eating disorders
WO2009080693A2 (en) *	2007-12-20	2009-07-02	Neurosearch A/S	Pharmaceutical composition comprising tesofensine or its analogue and a beta blocker
CA2709861A1 (en)	2007-12-20	2009-07-02	Neurosearch A/S	Pharmaceutical compositions
US9408837B2 (en)	2008-05-28	2016-08-09	Kitov Pharmaceutical Ltd.	Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
EP2814473B1 (en) *	2012-02-16	2018-10-10	Saniona A/S	Pharmaceutical compositions for combination therapy
SI3265126T1 (sl) *	2015-03-03	2021-11-30	Saniona A/S	Formulacija kombinacije tezofenzina in metoprolola

2013
- 2013-02-14 EP EP13703834.5A patent/EP2814473B1/en active Active
- 2013-02-14 ES ES13703834T patent/ES2704987T3/es active Active
- 2013-02-14 JP JP2014557034A patent/JP6203760B2/ja active Active
- 2013-02-14 CA CA2864264A patent/CA2864264C/en active Active
- 2013-02-14 EA EA201491532A patent/EA029543B1/ru not_active IP Right Cessation
- 2013-02-14 PL PL13703834T patent/PL2814473T3/pl unknown
- 2013-02-14 US US14/379,032 patent/US9211271B2/en active Active
- 2013-02-14 AU AU2013220424A patent/AU2013220424B2/en active Active
- 2013-02-14 CN CN201810575583.9A patent/CN108434129A/zh active Pending
- 2013-02-14 WO PCT/EP2013/052941 patent/WO2013120935A1/en active Application Filing
- 2013-02-14 CN CN201380020405.5A patent/CN104244935A/zh active Pending
- 2013-02-14 CN CN201810580312.2A patent/CN108853071A/zh active Pending
- 2013-02-14 SI SI201331313T patent/SI2814473T1/sl unknown
- 2013-02-14 LT LTEP13703834.5T patent/LT2814473T/lt unknown
- 2013-02-14 DK DK13703834.5T patent/DK2814473T3/en active
2015
- 2015-06-12 HK HK15105603.1A patent/HK1204946A1/xx unknown
- 2015-11-10 US US14/936,963 patent/US9387184B2/en active Active
2016
- 2016-07-11 US US15/206,477 patent/US20170007557A1/en not_active Abandoned
2018
- 2018-02-27 US US15/906,350 patent/US20180185304A1/en not_active Abandoned
2019
- 2019-01-08 HR HRP20190050TT patent/HRP20190050T1/hr unknown
2021
- 2021-07-27 US US17/386,098 patent/US20220016055A1/en active Pending

Also Published As

Publication number	Publication date
US20160074344A1 (en)	2016-03-17
US20170007557A1 (en)	2017-01-12
ES2704987T3 (es)	2019-03-21
CN108434129A (zh)	2018-08-24
US9211271B2 (en)	2015-12-15
CA2864264A1 (en)	2013-08-22
CN104244935A (zh)	2014-12-24
WO2013120935A1 (en)	2013-08-22
CN108853071A (zh)	2018-11-23
EA201491532A1 (ru)	2015-01-30
JP6203760B2 (ja)	2017-09-27
AU2013220424B2 (en)	2017-03-23
HRP20190050T1 (hr)	2019-03-08
US20220016055A1 (en)	2022-01-20
EP2814473A1 (en)	2014-12-24
DK2814473T3 (en)	2019-01-28
US20180185304A1 (en)	2018-07-05
SI2814473T1 (sl)	2019-03-29
US20150025107A1 (en)	2015-01-22
JP2015508765A (ja)	2015-03-23
LT2814473T (lt)	2019-01-25
AU2013220424A1 (en)	2014-09-25
CA2864264C (en)	2020-05-05
HK1204946A1 (en)	2015-12-11
EP2814473B1 (en)	2018-10-10
EA029543B1 (ru)	2018-04-30
US9387184B2 (en)	2016-07-12

Publication	Publication Date	Title
HK1206297A1 (en)	2016-01-08	Pharmaceutical compositions for combination therapy
ZA201703992B (en)	2019-12-18	Inhalable pharmaceutical compositions
HK1213798A1 (zh)	2016-07-15	治療性化合物和組合物
HK1209638A1 (en)	2016-04-08	Pharmaceutical compositions
ZA201501930B (en)	2016-01-27	Pharmaceutical composition
HRP20190050T1 (hr)	2019-03-08	Farmaceutski pripravci za kombinacijsku terapiju
EP2832730A4 (en)	2015-09-09	MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
HK1209047A1 (en)	2016-03-24	Novel pharmaceutical composition
GB201420971D0 (en)	2015-01-07	Therapeutic composition
IL217807A0 (en)	2012-06-28	Therapeutic compositions
ZA201502987B (en)	2016-11-30	Pharmaceutical composition
EP2897590A4 (en)	2016-05-04	PHARMACEUTICAL COMPOSITION
GB201211153D0 (en)	2012-08-08	Pharmaceutical compositions
HK1209339A1 (en)	2016-04-01	Pharmaceutical formulations
EP2851078A4 (en)	2015-10-21	PHARMACEUTICAL COMPOSITION
HUE043019T2 (hu)	2019-07-29	Gyógyszerészeti készítmények kombinációs terápia céljára
IL238075A0 (en)	2015-05-31	pharmaceutical preparations
ZA201400751B (en)	2014-12-25	Pharmaceutical composition
GB201219234D0 (en)	2012-12-12	Pharmaceutical compositions
GB201213303D0 (en)	2012-09-05	Pharmaceutical compositions
GB201204810D0 (en)	2012-05-02	Pharmaceutical compositions
GB201221130D0 (en)	2013-01-09	New pharmaceutical composition
GB201207701D0 (en)	2012-06-13	New pharmaceutical composition
GB201207628D0 (en)	2012-06-13	New pharmaceutical composition
GB201211403D0 (en)	2012-08-08	Pharmaceutical formulations